Xilio Therapeutics Inc
NASDAQ:XLO
Balance Sheet
Balance Sheet Decomposition
Xilio Therapeutics Inc
Xilio Therapeutics Inc
Balance Sheet
Xilio Therapeutics Inc
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
49
|
19
|
198
|
120
|
45
|
55
|
|
| Cash Equivalents |
49
|
19
|
198
|
120
|
45
|
55
|
|
| Other Current Assets |
2
|
1
|
5
|
4
|
3
|
5
|
|
| Total Current Assets |
51
|
21
|
203
|
125
|
48
|
60
|
|
| PP&E Net |
10
|
14
|
14
|
13
|
11
|
9
|
|
| PP&E Gross |
10
|
14
|
14
|
13
|
11
|
9
|
|
| Accumulated Depreciation |
0
|
1
|
3
|
4
|
6
|
7
|
|
| Other Long-Term Assets |
2
|
2
|
2
|
2
|
2
|
2
|
|
| Total Assets |
63
N/A
|
36
-42%
|
218
+501%
|
139
-36%
|
61
-56%
|
71
+17%
|
|
| Liabilities | |||||||
| Accounts Payable |
3
|
5
|
3
|
3
|
1
|
3
|
|
| Accrued Liabilities |
3
|
14
|
10
|
11
|
12
|
11
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
2
|
0
|
7
|
3
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
14
|
|
| Total Current Liabilities |
5
|
22
|
13
|
21
|
16
|
27
|
|
| Long-Term Debt |
10
|
8
|
10
|
3
|
0
|
0
|
|
| Other Liabilities |
9
|
12
|
10
|
9
|
8
|
26
|
|
| Total Liabilities |
24
N/A
|
42
+72%
|
33
-22%
|
34
+3%
|
24
-28%
|
53
+122%
|
|
| Equity | |||||||
| Common Stock |
68
|
78
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
30
|
85
|
161
|
249
|
326
|
384
|
|
| Additional Paid In Capital |
0
|
2
|
346
|
355
|
362
|
401
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
39
N/A
|
5
N/A
|
185
N/A
|
106
-43%
|
37
-65%
|
18
-52%
|
|
| Total Liabilities & Equity |
63
N/A
|
36
-42%
|
218
+501%
|
139
-36%
|
61
-56%
|
71
+17%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
27
|
27
|
27
|
27
|
28
|
46
|
|